lenalinomide
Showing 1 - 1 of 1
Follicular Lymphoma and Marginal Zone Lymphoma Trial in Beijing (Recombinant Humanized Monoclonal Antibody MIL62, lenalinomide,
Recruiting
- Follicular Lymphoma and Marginal Zone Lymphoma
- Recombinant Humanized Monoclonal Antibody MIL62, lenalinomide
- lenalinomide
-
Beijing, ChinaChinese Academy of Medical Sciences and Peking Union Medical Col
Feb 13, 2022